Instead enhancer loss occurs in Léri-Weill syndrome and BPES (Blepharophimosis, ptosis, epicanthus inversus syndrome), in which deletions of SHOX (Léri-Weill) or FOXL2 (BPES) enhancers are reported (50,51). Here, FOXL2 is linked to Blepharophimosis.